Drugs / PF-06755990
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02616185 | Dec 2015 → Feb 2021 | prostate neoplasm | Pfizer | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-06755990 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02616185 ↗ |
| Modality | Vaccine | “vaccine-based immunotherapy regimen” NCT02616185 ↗ |
| Route | Intramuscular | “patients with mCRPC received intramuscular PrCa VBIR” PMID 36948505 ↗ Mar 2023 |